Canadawhartonmedicalclinic.com
Wharton Medical Clinic is a Canadian healthcare organization focused on the medical management of obesity and related metabolic conditions. The clinic provides physician-led, evidence-based programs that integrate nutrition and lifestyle counselling, behavioral support, and pharmacotherapy to address weight, cardiometabolic risk factors, and obesity-related comorbidities.
In addition to patient care, Wharton Medical Clinic participates in clinical research on obesity treatment, including studies of anti-obesity medicines and real-world outcomes. The clinic collaborates with academic and industry partners to evaluate safety, efficacy, and patient-reported outcomes for emerging therapies, contributing data that inform best practices in chronic weight management.
None yet. When a new project in the record names Wharton Medical Clinic as owner, partner or investor, it shows here.
Oral semaglutide 25 mg shows significant weight loss and improved physical activity in a 64-week trial, with mild to moderate side effects, pending FDA approval.
